1. Stocks
    2. /
  2. Vectura Group (LSE: VEC)
    3. /

LSE:VEC (Vectura Group)

About vec

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.
Financial Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Vectura Group (LSE: VEC)
Latest News

Investing Articles

Are these bombed-out pharma stocks worth buying?

| Rupert Hargreaves

Should you catch these falling knives?

Read more »

Investing Articles

2 FTSE 250 bargains I’d buy before it’s too late

| G A Chester

These FTSE 250 (INDEXFTSE:MCX) stocks look set for strong growth.

Read more »

Investing Articles

Forget short-term pain: 2 growth stocks for long-term gain!

| Royston Wild

Royston Wild discusses two growth lovelies for long-term investors.

Read more »

Growth
Investing Articles

Why this growth stock could double by 2019

| Bilaal Mohamed

Bilaal Mohamed reckons this pharmaceutical stock could double within the next couple of years.

Read more »

Investing Articles

2 shares with explosive long-term growth potential

| Rupert Hargreaves

These stocks have the potential to produce growth for years to come.

Read more »

Investing Articles

3 growth stocks I’d buy right now

| Alan Oscroft

The next few years could see rich pickings among growth shares.

Read more »

Investing Articles

Top stocks for February

| The Motley Fool Staff

We asked our analysts to share their top stock picks for the coming month.

Read more »

Investing Articles

One growth stock I’d buy and one I’d sell in February

| G A Chester

G A Chester reveals one mid-cap he'd buy and one he'd sell.

Read more »